Status:
UNKNOWN
Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver Disease
Lead Sponsor:
Assiut University
Conditions:
NAFLD
Eligibility:
All Genders
17-70 years
Brief Summary
The investigators aim to evaluate patients with NAFLD for early echocardiographic signs of myocardial dysfunction and if there is any correlation between the degree of steatosis or fibrosis and the de...
Detailed Description
Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD) have abnormal myocardial energy metabolism and reduced coronary functional capacity, even in the absence of risk factors for cardiovascular d...
Eligibility Criteria
Inclusion
- all NAFLD patients who will be seen in the outpatient clinic in our hospital. Diagnosis of NAFLD will be based on clinical history and examination, imaging and fibroscan results
Exclusion
- Children less than 16 years
- Adults more than 70 years
- Known advanced cardiovascular disease as:
- advanced heart failure with reduced ejection fraction (HFrEF)
- history of recent acute myocardial event as acute coronary syndrome
- symptomatic chronic myocardial ischemia
- Known or recent diagnosis of rheumatic heart disease
- Known or recent diagnosis of congenital heart disease
- Advanced comorbidities: advanced cancer, chronic kidney disease, advanced liver disease (decompensated cirrhosis), and advanced pulmonary disease.
Key Trial Info
Start Date :
November 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2025
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT06130202
Start Date
November 20 2023
End Date
December 20 2025
Last Update
November 14 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.